Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab.

Landi D, Grimaldi A, Bovis F, Ponzano M, Fantozzi R, Buttari F, Signoriello E, Lus G, Lucchini M, Mirabella M, Cellerino M, Inglese M, Cola G, Nicoletti CG, Mataluni G, Centonze D, Marfia GA.